Top Tweets for #TUXEDO2
From clinical trial to global scientific recognition—the #TUXEDO2 India Study highlights how strong clinical evidence advances cardiovascular care through leading conferences and peer-reviewed publications.
#ClinicalResearch #Cardiology #JACC #JAMA #ClinicalTrial #CliceboSolution
TUXEDO-2 tertiary endpoint analysis is now published in JAMA Cardiology (IF 14.1).
1,800 patients | 66 Indian sites
Ticagrelor was not noninferior to prasugrel at 1 year.
Led by Dr. Upendra Kaul & Dr. Sripal Bangalore. CRO: Clicebo Solutions.
#TUXEDO2 #JAMACardiology #SMT
The India-led #TUXEDO2 trial made a global impact at #AHA2025 — enrolling 1,800+ patients across 66 centres and showing a 30% reduction in major adverse events with Prasugrel vs Ticagrelor.
Proud CRO partner. 🇮🇳
#Clicebo #ClinicalTrials #Cardiology #LateBreakingTrial #CRO
In the #Tuxedo2 #RCT of 1800 patients with #T2DM & #MVD in India undergoing #PCI, #ticagrelor not proven non-inferior to #prasugrel on PEP of #MACE
Point estimates favoured prasugrel across endpoints
Non-inferiority margin 5%
Congrats @SripalBangalore & team
#AHA25
@mmamas1973
🎙️NEW #AHA25 Late Breaker Discussion ✨ Dr @SripalBangalore joins host 🌟Dr @hvanspall to discuss findings from the TUXEDO-2 trial
📽️Watch here👉 https://t.co/r2TUfqZ9xl
📊#Ticagrelor did not meet non-inferiority compared to #prasugrel when added to aspirin as part of dual antiplatelet therapy in patients with multivessel disease undergoing #PCI.
#DAPT #AHA2025 #CardioTwitter
Join us at hashtag#TCT2025, for the Late-Breaking Trial Presentation of TUXEDO-2, comparing Supraflex Cruz vs. Xience in patients with diabetes and multivessel coronary artery disease. #SupraflexCruz #Tuxedo2 #LBT #SMT #InterventionalCardiology #TCT2025
Join us at #TCT2025 to witness the latest #ClinicalTrial results of #SupraflexCruz!
Featuring key Late-Breaking & Abstract Presentations -refer to the summary below for full session details. #SMT #InterventionalCardiology #TUXEDO2 #MultivesselTalent #SFLEXNetherlands #CruzSenior
we extend our gratitude to the patients, investigators, and clinical partners who have contributed to the successful enrolment of this trial.
#cardiovascular #CardioTwitter #SMT #Tuxedo2
https://t.co/uFnHhBzNim
As the world is celebrating Diabetes day, we have brought you some global updates from the Tuxedo trial
#WorldDiabetesDay #tuxedo2 #CardioTwitter
Watch @Tuxedo's new video, "2nd Time Around" » https://t.co/6acuIV6IXN
(@MayerHawthorne @JakeUno)
#Tuxedo2, out now!
So far everybody said a different song 😂 #Tuxedo2
Mayer Hawthorne and Jake One are back as Tuxedo! The duo will release their new album #Tuxedo2 on March 24th!... https://t.co/JLHOi2skt7
The gorgeous @yslbeauty #tuxedo2 palette still makes me smile when I open it. #bbloggers #… https://t.co/7pnwQga111
Last Seen Hashtags on Sotwe
omegle(*)*************
Thundr
Seen from Chile
鞍馬寺本堂
Seen from United States
veteransRealty
Seen from United States
非人権
Seen from United States
funk99666
Seen from United States
operatingdepartmentpractitionerday
Seen from United States
MientoComoAmlo
Seen from United States
evli turbanli
Seen from Turkey
ometv
Seen from Switzerland
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.9M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.1M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers